Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Ramesh Velu"'
Autor:
Shivshankar Thanigaimani, PhD, James Phie, PhD, Frank Quigley, MD, Michael Bourke, MD, Bernie Bourke, MD, Ramesh Velu, MD, Jason Jenkins, MD, Jonathan Golledge, MA, FRCS, FRACS
Publikováno v:
JVS - Vascular Science, Vol 3, Iss , Pp 306-313 (2022)
Background: In the present study, we examined the association of immunosuppressant drug prescriptions with the growth of small abdominal aortic aneurysms (AAAs). Methods: Participants with an AAA measuring between 30 and 50 mm were recruited from fou
Externí odkaz:
https://doaj.org/article/3e2860aba4364e88b4af179a4d8313b4
Autor:
Jonathan Golledge, Sophie Rowbotham, Ramesh Velu, Frank Quigley, Jason Jenkins, Michael Bourke, Bernie Bourke, Shivshankar Thanigaimani, Dick C. Chan, Gerald F. Watts
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 6 (2020)
Background The aim of this study was to assess the relationship between serum lipoprotein (a) (Lp[a]) concentration and the requirement for peripheral artery disease (PAD) operations or incidence of major adverse cardiovascular events. Methods and Re
Externí odkaz:
https://doaj.org/article/674cb330c4474187a71a46e34e127f3e
Publikováno v:
PLoS ONE, Vol 15, Iss 11, p e0241802 (2020)
ObjectiveTo assess whether survival and clinical events following elective abdominal aortic aneurysm (AAA) repair were associated with remoteness of residence in North Queensland, Australia.MethodsThis retrospective cohort study included participants
Externí odkaz:
https://doaj.org/article/1a1a75a364154abc887b906b7168f955
Autor:
Sophie E. Rowbotham, Jenna L. Pinchbeck, Georgina Anderson, Bernie Bourke, Michael Bourke, T. Christian Gasser, Rene Jaeggi, Jason S. Jenkins, Corey S. Moran, Susan K. Morton, Christopher M. Reid, Ramesh Velu, Lisan Yip, Joseph V. Moxon, Jonathan Golledge
Publikováno v:
Trials, Vol 18, Iss 1, Pp 1-10 (2017)
Abstract Background An abdominal aortic aneurysm (AAA) is a focal dilation of the abdominal aorta and is associated with a risk of fatal rupture. Experimental studies suggest that myo-inositol may exert beneficial effects on AAAs through favourable c
Externí odkaz:
https://doaj.org/article/729c7f8d1edf43549b747094e3d31d45
Autor:
Jenna L. Pinchbeck, Joseph V. Moxon, Sophie E. Rowbotham, Michael Bourke, Sharon Lazzaroni, Susan K. Morton, Evan O. Matthews, Kerolos Hendy, Rhondda E. Jones, Bernie Bourke, Rene Jaeggi, Danella Favot, Frank Quigley, Jason S. Jenkins, Christopher M. Reid, Ramesh Velu, Jonathan Golledge
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 19 (2018)
Background There is no drug therapy for abdominal aortic aneurysm (AAA). FAME‐2 (Fenofibrate in the Management of Abdominal Aortic Aneurysm 2) was a placebo‐controlled randomized trial designed to assess whether administration of 145 mg of fenofi
Externí odkaz:
https://doaj.org/article/d10f5da433004a3bacc6e93f9578f888
Publikováno v:
Journal of Vascular Surgery. 77:1037-1044
The primary aim of this study was to test which of a group of four inflammation and thrombosis biomarkers were independently predictive of major adverse cardiovascular events (MACE) in patients with small abdominal aortic aneurysm (AAA).471 participa
Autor:
Bernie Bourke, Frank Quigley, Jonathan Golledge, Shivshankar Thanigaimani, James Phie, Michael J. Bourke, Jason Jenkins, Ramesh Velu
Publikováno v:
Annals of Vascular Surgery. 79:256-263
Background Depression is associated with an increased risk of cardiovascular events but its association with abdominal aortic aneurysm (AAA) progression is unknown. This study examined if a diagnosis of depression was association with more rapid AAA
Publikováno v:
In Asian Pacific Journal of Tropical Disease 2015 5 Supplement 1:S59-S66
Publikováno v:
European Journal of Vascular and Endovascular Surgery. 62:960-968
Objective The aim of this study was to examine whether there were independent associations between abdominal aortic diameter, size index, and height index and the risk of major adverse events in patients referred for treatment of various types of aor
Publikováno v:
Heart, Lung and Circulation. 30:1552-1561
The costs of open and endovascular revascularisation to treat peripheral artery disease (PAD) have not been fully established. This study examined the costs of both the index admission and any readmissions to hospital within 30 days of discharge for